Charles River Laboratories | Beneficio Operativo



Operating Profit Cambio Fecha
Agilent USD 376M 32M 2025-01
Align Technology USD 144.15M 18.15M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Bruker USD 64.1M 4M 2024-12
Cardinal Health USD 549M 19M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Cigna USD 2.3B 4M 2024-12
CVS Health USD 2.86B 2.03B 2024-12
Danaher USD 1.42B 467M 2024-12
Dentsply International USD -509000000 47M 2024-12
Elevance Health USD 946M 727M 2024-12
Galapagos EUR -62720000 8.41M 2024-12
Hologic USD 229.8M 200K 2024-12
Humana USD -543000000 1.27B 2024-12
Illumina USD 175M 566M 2024-12
Incyte USD 301.51M 155.43M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Laboratory Of America USD 216.5M 37.6M 2024-12
Lonza CHF 534M 194M 2024-06
McKesson USD 1.22B 646M 2024-12
Merck EUR 1.1B 305M 2024-09
Mettler Toledo International USD 314.55M 295.95M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Quest Diagnostics USD 361M 8M 2024-12
Revvity USD 118.75M 20.6M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
UnitedHealth USD 7.79B 894M 2024-12
Walgreens Boots Alliance USD -213000000 452M 2024-11
Waters USD 292.26M 81.13M 2024-12
West Pharmaceutical Services USD 159.6M 1.7M 2024-12



Charles River Laboratories Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.